A newly discovered receptor switch that boosts bone growth could transform how we treat osteoporosis, by stimulating the body’s own bone-building machinery using a targeted drug and even mechanical ...
A recent study identifies Neural EGFL-like 2 (NELL2), a secreted protein, as a key regulator of bone homeostasis, offering potential therapeutic applications for osteoporosis. NELL2 promotes ...
Teeth naturally wear down over time, but scientists have found that they could signal certain cells to regrow bones, opening ...
As we age, the health of our bones becomes increasingly important. Osteoporosis, a condition characterized by weakened bones, affects millions, leading to fractures and reduced quality of life. Among ...
In our bones, specialized cells called osteoblasts are responsible for building up bone substance. A team of researchers has now identified an enzyme that controls the activity of osteoblasts. An ...
The Discovery of New Members of the TNF Receptor and Ligand Families and Their Relationship to Osteoclasts and Bone Metabolism Binding of RANKL to RANK initiates a signaling cascade, which includes ...
Sustained hypoxia affects orthodontic tooth movement (OTM) by altering osteoclast and osteoblast differentiation, report researchers from the Institute of Science Tokyo, Japan. Hypoxic conditions ...
After 30s, bone breakdown slowly begins to outpace formation and increases the risk of fracture and osteoporosis. However, women who adopt bone-care habits have shown slow bone loss and maintain ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback